Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection

Clinical trial NCT07729839 · RECRUITING

Trial details

NCT number: NCT07729839
Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Participants

Start date: 2026-05-31
Primary completion: 2026-12-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.